Effect of Hypercholesterolemia With or Without Hypertension on Coronary Artery Stenosis in Patients With Angina: a Retrospective Study
1 other identifier
observational
1,000
1 country
1
Brief Summary
A multicenter, retrospective clinical study was carried out in the medical records management system of 6 hospitals in Tianjin. Patients who were suffered with Coronary heart disease angina pectoris and underwent coronary angiography are collected. The investigators collect and analyze the demographics, laboratory information, clinical outcome data, and coronary angiographic data of patients. To explore the correlation between hypercholesterolemia and the degree of coronary artery stenosis of Coronary heart disease angina pectoris, and to further research the influence of hypertension on total cholesterol level and coronary artery stenosis, and provide guidance for clinical prevention and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2020
CompletedFirst Posted
Study publicly available on registry
June 23, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedJune 23, 2020
June 1, 2020
6 months
June 17, 2020
June 21, 2020
Conditions
Outcome Measures
Primary Outcomes (16)
Fasting blood glucose in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the fasting blood glucose data of the first day of hospitalization of the patients.
one year
Glycated hemoglobin in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the glycated hemoglobin data of the first day of hospitalization of the patients.
one year
Total cholesterol in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the total cholesterol data of the first day of hospitalization of the patients.
one year
Triglyceride in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the triglyceride data of the first day of hospitalization of the patients.
one year
Low density lipoprotein cholesterol in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the low density lipoprotein cholesterol data of the first day of hospitalization of the patients.
one year
High density lipoprotein cholesterol in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the high density lipoprotein cholesterol data of the first day of hospitalization of the patients.
one year
C-reactive protein in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the C-reactive protein data of the first day of hospitalization of the patients.
one year
Fibrinogen in clinical biochemical tests.
In the hospital medical record management system, the investigators collect the fibrinogen data of the first day of hospitalization of the patients.
one year
Coronary angiography data in imaging examination.
In the hospital medical record management system, the investigators collect coronary angiography data of the patient's hospitalization.
one year
Age in demographics.
In the hospital medical record management system, the investigators collect the age data of the first day of hospitalization of the patients.
one year
Gender in demographics.
In the hospital medical record management system, the investigators collect the gender data of the first day of hospitalization of the patients.
one year
Ethnicity in demographics.
In the hospital medical record management system, the investigators collect the ethnicity data of the first day of hospitalization of the patients.
one year
Weight in demographics.
In the hospital medical record management system, the investigators collect the weight data of the first day of hospitalization of the patients.
one year
Smoking in demographics.
In the hospital medical record management system, the investigators collect the smoking data of the first day of hospitalization of the patients.
one year
Medical history in demographics.
In the hospital medical record management system, the investigators collect the medical history data of the first day of hospitalization of the patients.
one year
Blood pressure in demographics.
In the hospital medical record management system, the investigators collect the blood pressure data of the first day of hospitalization of the patients.
one year
Secondary Outcomes (2)
Evaluate the correlation between total cholesterol level and the degree of coronary artery stenosis
one year
Assess the effect of with or without hypertension on the correlation between total cholesterol level and the degree of coronary artery stenosis
one year
Study Arms (6)
NTC/-HTN group
Patients with TC \< 5.18 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to normal TC/ none hypertension(NTC/-HTN) group.
NTC/+HTN group
Patients with TC \< 5.18 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg belong to normal TC/ hypertension(NTC/+HTN) group.
BHTC/-HTN group
Patients whose TC is 5.18 ≤ TC \< 6.19 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to borderline-high TC/ none hypertension (BHTC/-HTN) group.
BHTC/+HTN group
Patients whose TC is 5.18 ≤ TC \< 6.19 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg belong to borderline-high TC/ hypertension (BHTC/+HTN) group.
HTC/-HTN group
Patients with TC ≥6.19 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to high TC/ none hypertension(HTC/-HTN) group.
HTC/+HTN group
Patients with TC ≥6.19 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥ 80 mmHg belong to high TC/ hypertension(HTC/+HTN) group.
Eligibility Criteria
The collaborative network of Coronary heart disease research medical units formed by the research team includes the First affiliated Hospital of Tianjin University of traditional Chinese Medicine, the Second affiliated Hospital of Tianjin University of traditional Chinese Medicine, Tianjin Nankai Hospital, the affiliated Hospital of Tianjin Institute of traditional Chinese Medicine, Tianjin chest Hospital and Tianjin Medical University General Hospital.
You may qualify if:
- Patients aged from 35 to 75 years old, male or female.
- Those who were hospitalized between September 1, 2014 and September 1, 2019.
- Patients with Coronary heart disease angina pectoris and have undergone coronary angiography in the inpatient department of cardiovascular internal medicine.
- The diagnosis of hypercholesterolemia, Coronary heart disease angina pectoris and hypertension is accorded with the diagnostic criteria.
You may not qualify if:
- Those with other cardiac diseases, gastroesophageal reflux disease or hiatal hernia, neurosis, spinal or vertebral artery cervical spondylosis, hyperthyroidism, climacteric syndrome, etc.
- Those with myocarditis, cardiomyopathy, acute myocardial infarction, third degree of heart failure, severe heart valve disease, major diseases such as malignant tumor and serious metabolic diseases, liver failure or renal failure.
- Those with psychotic disorders, or cognitive dysfunction.
- Those of childbearing age and have fertility requirements, or pregnant women or lactating women.
- Those allergic to iodine contrast medium.
- Those who are not suitable for the study, as judged by the researcher.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, 300193, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- researcher
Study Record Dates
First Submitted
June 17, 2020
First Posted
June 23, 2020
Study Start
September 1, 2020
Primary Completion
March 1, 2021
Study Completion
September 1, 2021
Last Updated
June 23, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share